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Abstract
Despite the global prevalence of gastric disease, there are few adequate models to study the fundus 
epithelium of the human stomach. We differentiated human pluripotent stem cells (PSCs) into 
gastric organoids containing fundic epithelium by first identifying and then recapitulating key 
events in embryonic fundus development. We found that disruption of Wnt/β-catenin signaling in 
mouse embryos led to conversion of fundic to antral epithelium, while β-catenin activation in 
hPSC-derived foregut progenitors promoted the development of human fundic-type gastric 
organoids (hFGOs). We then used hFGOs to identify temporally distinct roles for multiple 
signaling pathways in epithelial morphogenesis and differentiation of fundic cell types, including 
chief cells and functional parietal cells. While hFGOs are a powerful new model for studying the 
development of the human fundus and its lineages, they also represent a critical new model system 
to study the molecular basis of human gastric physiology, pathophysiology, and drug discovery.
Introduction
Recently, considerable progress has been made in the development of three-dimensional in 
vitro organoid systems1,2. Organoids have proven to be powerful experimental models that 
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combine architectural complexity and cellular diversity with the tractability and scalability 
of traditional cell culture methods. Organoid generation through directed differentiation of 
pluripotent stem cells (PSCs; comprising both embryonic stem cells and induced PSCs) 
offers several advantages over other approaches including an unlimited source of starting 
material, no requirement for surgical acquisition of tissue, and ease of genetic 
manipulations. Further, PSC-based methods permit direct investigation of mechanisms 
underlying normal and aberrant human development3. However, differentiating PSCs into 
specific organoid types depends on a robust molecular knowledge of normal organ 
development. For some organs, such as the stomach, there are large gaps in our 
understanding of molecular pathways that drive embryonic development.
The stomach is one of the most structurally diverse organs among mammals4. In humans, 
the gastric mucosa generally consists of two types of epithelial glands5,6. Located in the 
more proximal anatomic domains – the corpus and fundus – of the stomach, oxyntic glands 
comprise acid-secreting parietal cells, protease-producing chief cells, mucus-producing 
cells, and endocrine cells. Antral-type glands, located in the more distal antrum and pylorus, 
contain mostly mucous and endocrine cells. In order to simplify the anatomic- and species-
specific systems of nomenclature, we will use the terms ‘fundus’ and ‘antrum’ to broadly 
describe these two histologic types of gastric epithelia. We previously developed a method to 
direct the differentiation of hPSCs into three-dimensional gastric tissue (human gastric 
organoids; hGOs) that contained a pure antral epithelium with normal antral cell types7. 
While the antral hGOs (hAGOs) are a robust system for studying antral lineage allocation 
and host-microbe interactions in the stomach, they do not allow for studies of fundic biology 
and disease. More recently, Noguchi et. al. successfully differentiated mouse ESCs into 
organoids comprising various types of mouse gastric tissue8. However, this approach used 
mouse ESC aggregation and spontaneous differentiation resulting in organoids that were 
heterogeneous, evidenced by the presence of stratified epithelia. Moreover, species 
differences make the mouse stomach suboptimal for modeling human gastric disease9. Thus, 
a robust and efficient PSC-derived model of the human fundus epithelium would represent a 
significant advance in the field of gastric biology.
Embryonic organ development is guided by a series of instructive cues between neighboring 
tissues10,11, and differentiation of hPSCs into specific lineages has relied heavily on use of 
these signals to direct differentiation in vitro. We previously identified a step-wise 
differentiation approach to generate hAGOs, whereby hPSCs were differentiated into 
definitive endoderm, patterned to posterior foregut, then specified into presumptive antral 
epithelium7. We hypothesized that the fundus and antrum derive from a common population 
of posterior foregut progenitors, which could be directed toward the fundic lineage if 
provided with the appropriate signals. However, given that the mechanisms that drive fundus 
development in vivo were not previously known, we first had to identify signaling pathways 
that pattern the embryonic stomach along the proximal-distal axis.
Embryonic stomach pattern formation
To aid investigation of the pathways that regulate fundus specification during embryonic 
development, we analyzed mouse embryos to identify molecular markers that could 
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distinguish between presumptive fundus, antrum and forestomach. At E14.5 we found that 
Sox2 was expressed in all foregut organ lineages while Gata4 was restricted to the glandular 
stomach epithelium. Within the Gata4+ domain, Pdx1 was specific to the presumptive antral 
region (Extended Data Figure 1a); thus, the embryonic fundus domain is Sox2+Gata+Pdx1−. 
Further, we analyzed published microarray datasets (GSM326648-GSM32665012 and 
GSM80809-GMS8081613) and dissected regions of the E14.5 foregut to demonstrate that 
expression of the transcription factors Irx2, Irx3, and Irx5 was greater than ten-fold enriched 
in the embryonic fundus compared to antrum (Extended Data Figure 1b–c), indicating that 
their expression can further distinguish between regions of the glandular gastric epithelium.
At the molecular level, the presumptive fundic and antral domains of the stomach were 
already established by E10.5 (Figure 1a). At that point in development, the canonical Wnt 
signaling pathway was active in the proximal stomach but exhibited little or no activity in 
the distal stomach14, as shown using the Wnt reporter mouse strain Axin2-lacZ (Figure 1b). 
While the regulation of Wnt/β-catenin signaling is known to play a role in establishing the 
pyloric-duodenal boundary14,15, its role in gastric epithelial patterning had not been 
investigated. To determine whether Wnt/β-catenin signaling was functionally required for 
establishing the fundus in vivo, we deleted β-catenin (Ctnnb1) in the foregut epithelium 
using Shh-cre (Shh-cre;β-cateninfl/fl = cKO). Disruption of Wnt/β-catenin signaling resulted 
in the loss of fundic identity, demonstrated by ectopic Pdx1 expression in the fundus at 
E10.5 (Figure 1c). Ectopic Pdx1 was initially restricted to the ventral half of the fundic 
epithelium, consistent with previously reported recombination activity using this Shh-cre 
line16, but it then expanded over time to include a majority of the proximal stomach and 
greater curvature by E14.5 (Extended Data Figure 2a). Additionally, expression of the 
fundus markers Irx2, Irx3, and Irx5 were dramatically reduced in the cKO embryos 
(Extended Data Figure 2b). Collectively, these data support the conclusion that epithelial 
Wnt/β-catenin signaling regulates gastric pattern formation, as it is required for the initial 
specification of fundus identity while repressing antral fate in the embryonic mouse 
stomach.
To determine the impact of early Wnt/β-catenin-mediated patterning abnormalities on 
subsequent cytodifferentiation, we analyzed cKO embryos at E18.5. The stomach in cKO 
embryos was malformed and reduced in size at E18.5 (Figure 1d and Extended Data Figure 
2c–d), suggestive of a role for Wnt/β-catenin in promoting stomach growth during late 
stages of development. Moreover, the cKO stomach was completely mis-patterned with 
ectopic Pdx1 expression throughout the proximal-most regions of the epithelium (Figure 
1d). Parietal cells, a fundic cell type marked by expression of Atp4b, were reduced in the 
CKO stomach (Figure 1d) and completely absent in β-catenin deficient epithelium (Figure 
1e). In contrast, the parietal cells that did develop were only observed in β-catenin-
expressing epithelium (Figure 1e and Extended Data Figure 2d–e). Taken together, these in 
vivo data support a model by which Wnt/β-catenin signaling induces fundus specification 
and inhibits antral identity. Further, disruption of this early patterning coincides with 
subsequent cell autonomous loss of parietal cells, suggesting that cytodifferentiation is 
impaired secondary to developmental patterning defects.
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Differentiation of fundic hGOs from hPSCs
We next investigated the role of Wnt/β-catenin signaling in establishing fundic-antral pattern 
of the developing human stomach. To model early stages of stomach differentiation, we 
started with a previously described protocol for differentiating hPSCs into antrum-like 
gastric organoids, which recapitulates the normal stages of early gastric development with 
high fidelity7. Starting with three-dimensional posterior foregut spheroids (SOX2+HNF1β+), 
we tested whether stimulation of Wnt/β-catenin signaling would direct posterior foregut 
epithelium into the fundic (SOX2+GATA+PDX1−) lineage rather than antrum 
(SOX2+GATA+PDX1+) during the gastric specification stage (Figure 2a). Indeed, activating 
β-catenin with the GSK3β inhibitor CHIR99021 (CHIR) for three days resulted in nearly 
complete repression of PDX1 at day 9, accompanied by significantly increased expression of 
IRX2, IRX3, and IRX5 (Figure 2b–c). Importantly, SOX2 and GATA4 levels were 
unaffected by CHIR treatment, confirming that spheroids retained their gastric identity. 
Thus, CHIR exposure resulted in formation of SOX2+GATA+PDX1− epithelium with 
increased IRX expression, a signature consistent with the presumptive fundic epithelium.
We then sought to determine whether CHIR-treated spheroids would further develop into 
more mature hGOs containing a fundus-like epithelium. Interestingly, a three-day pulse of 
CHIR from days 6–9 was not sufficient to irreversibly specify a fundic identity, as the hGOs 
ultimately reverted to a PDX1+ antral phenotype at later stages. However, continued Wnt 
stimulation via CHIR treatment through at least day 29 led to stable induction of fundic gene 
expression (Extended Data Figure 3a). This was consistent with the prolonged activity of 
Wnt/β-catenin signaling during embryonic stomach development in vivo. Although previous 
studies indicated that ectopic Wnt activation in the embryonic stomach promoted intestinal 
fate14,15, CHIR-treated hGOs did not exhibit a significant increase in intestinal markers 
CDX2, MUC2, CCK, or SCT (Extended Data Figures 3e and 4a–b). We further 
demonstrated that CDX2 remained suppressed despite Wnt/β-catenin activation due to 
concomitant inhibition of BMP signaling, as replacing Noggin with BMP4 led to robust 
expression of the intestinal transcription factor (Extended Data Figure 4c).
Once regional domains are established in early development, the primitive gastric epithelium 
undergoes periods of growth, glandular morphogenesis, and differentiation of definitive cell 
types. We previously showed that hAGOs underwent a similar progression of morphologic 
and cellular development7. CHIR-treated hFGOs grew at a similar rate and efficiency 
compared to hAGOs, as 75–90% of all spheroids plated grew into organoids (Extended Data 
Figure 3d). At day 20, both types of hGOs contained epithelia that expressed the gastric 
SOX2/GATA4 signature in >90% of cells, while PDX1 was restricted to hAGOs (87.1 
± 8.4% in hAGOs and 3.9 ± 2.0% in hFGOs, p=3.07×10−6; Extended Data Figure 3e). The 
organoids maintained their respective gastric identities throughout their development 
(Extended Data Figure 3b–c). By day 34, hFGOs and hAGOs comprised 
CDH1+CTNNB1+KRT8+ polarized, columnar epithelia that ubiquitously expressed the 
gastric-specific17 claudin CLDN18 (Figure 2e and Extended Data Figure 4d), as well as 
comparable undifferentiated mesenchymal cells (Extended Data Figure 5b). One notable 
difference was that hFGOs had a distinctive architecture with organized glands that bud from 
the organoid epithelium (Figure 2d–e and Extended Data Figure 5a), while hAGOs had 
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complex folding and primitive gland-like organization but rarely glandular buds7. Thus, the 
novel Wnt/β-catenin dependent mechanism of specifying fundus is conserved in humans and 
can be manipulated to generate three-dimensional hFGOs with a glandular epithelium that 
molecularly resembles the developing fundus.
Region-specific gastric cytodifferentiation
Differentiated antral gastric cell types were first detected in hAGOs around day 27 and then 
increased by day 347, analogous to the first few weeks of postnatal development in the 
mouse stomach18. At day 34, hFGOs contained both MUC5AC+ surface mucous cells and 
MUC6+ mucous neck cells as expected, similar to the hAGOs (Figure 3a–b and Extended 
Data Figure 6a). hFGOs also formed a variety of endocrine cell types (Figure 3c), but 
expression of the hormone GAST was specific to hAGOs while GHRL was enriched 10-fold 
in hFGOs (Figure 3d), consistent with the normal gastroendocrine pattern19. To functionally 
define the region-specific competence of hGOs, we used an inducible system to over-express 
the proendocrine transcription factor NEUROG3. Expression of NEUROG3 in both hGO 
subtypes resulted in robust expression of the pan-endocrine marker SYP, as well as the 
common gastric hormones SST and GHRL (Extended Data Figure 6c). However, only the 
hAGOs and not hFGOs were competent to give rise to GAST-expressing G-cells (Figure 3e 
and Extended Data Figure 6c), consistent with the antrum-specific distribution of G-cells in 
the human stomach19.
Chief cells, the fundus-specific secretory lineage, reside in the base of oxyntic glands and 
have been proposed as a type of reserve stem cell20. hFGOs exhibited epithelial expression 
of the chief cell-specific21 transcription factor MIST1 (Figure 4a), had 100–1,000-fold 
increases in transcripts for the proenzymes PGA5 and PGC (Figure 4c), and contained 
significantly increased pepsinogen content measured by ELISA (Figure 4e). However the 
transcript levels were less than 1% those found in the adult human stomach (Extended Data 
6d) and pepsinogen-positive cells were only rarely detectable by immunohistochemistry 
(Figure 4b–c). Consistent with this, zymogen granule-containing cells22 were identified by 
TEM (Figure 4d) but were rare. In contrast, cells with a more immature mucous granule 
pattern were abundant (Extended Data Figure 6b). Since chief cells in vivo do not exhibit 
robust pepsinogen expression for the first few weeks of life (Extended Data Figure 7a–b), 
we conclude that the chief cells were present in hFGOs but were immature. hFGOs therefore 
represent a robust platform to dissect the intrinsic and extrinsic mechanisms that regulate 
chief cell maturation.
Pathways controlling parietal cell differentiation
At baseline, hFGOs contained only a small number of parietal cells (PCs; Figure 5a–b), the 
defining cell type of fundic glands that acidify the gastric lumen via the proton pump 
(consisting of ATP4A and ATP4B subunits). Identification of efficient methods to increase 
PC populations has remained elusive due to a lack of understanding of the signaling 
mechanisms that drive their development. We therefore used PSC-derived hFGOs as a 
platform to functionally screen candidate signaling pathways for a role in regulating PC 
differentiation. For screening, we exposed day 30 hFGOs to signaling agonists or 
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antagonists for two days and analyzed PC differentiation at day 34. While the majority of 
signaling manipulations had no appreciable effect, transient inhibition of the MEK pathway 
with PD0325901 (PD03) resulted in substantial up-regulation of both ATP4A and ATB4B 
(Extended Data Figure 8a). Further, while BMP4 alone did not affect PC gene expression, it 
could enhance the effect of PD03 (data not shown). Thus, a two-day pulse of PD03/BMP4 
was sufficient to induce rapid and robust expression of PC markers ATP4A, ATP4B and GIF 
(Figure 5a–b and Extended Data Figure 8d). Interestingly, this effect was not observed by 
simply removing EGF or FGF from the culture medium (Extended Data Figure 8b), 
suggesting that there are likely endogenous signaling interactions upstream of MEK/ERK 
that are responsible for limiting PC differentiation in hFGO cultures. Further, PD03/BMP4 
treatment only affected the PC lineage (Extended Data Figure 8e), and was unable to induce 
PCs in hAGOs (Extended Data Figure 8c), further emphasizing that early patterning of the 
gastric epithelium defines its ultimate differentiation potential.
At day 34 hFGO epithelia exhibited comparable organization to the human stomach, with 
mucous cells lining the surface domain and PCs concentrated in the glandular portion 
(Figure 5e). Moreover, parietal cell morphology closely resembled maturing parietal cells in 
vivo (Figure 5c). Given their resemblance to PCs in vivo and their tubulovesicular 
ultrastructure as seen on TEM (Figure 5d), we hypothesized that the PCs in hFGOs would 
exhibit the ability to secrete acid in response to appropriate stimuli. Measured using a pH 
sensitive dye (SNARF5F) with real time confocal microscopy (Extended Data Figure 9a), 
hFGOs produced a swift and marked decrease in luminal pH in response to histamine that 
was blocked by either the H2 antagonist famotidine or the H+K+-ATPase antagonist 
omeprazole (Figure 5f and Extended Data Figure 9b). To visualize the cellular response to 
histamine, hGOs were cultured with the fluorescent dye acridine orange (AO), which shifts 
to an orange color when sequestered in acidic compartments23. Similar to isolated mouse 
gastric glands, AO accumulated in acidified cellular vesicles in hFGO glands in response to 
histamine (Figure 5g and Extended Data Figure 9c–d). These data indicate that the PCs 
underwent appropriate changes in secretory canalicular structure in response to acid-
inducing stimuli.
In vivo, differentiated gastric cell lineages are thought to derive from a common pool of 
undifferentiated stem or progenitor cells. Here we have demonstrated the ability to alter the 
relative proportions of cell types in hFGOs, either through genetic means (NEUROG3-
mediated regulation of endocrine cells) or by manipulation of extrinsic signaling pathways 
(PD03/BMP4 for PCs). These observations led to the hypothesis that hFGOs might contain a 
population of gastric stem cells analogous to those that have been isolated from the adult 
stomach. Indeed, we found that dissociated day 34 hFGOs could be passaged serially to give 
rise to new organoids (Extended Data Figure 10a–b). Re-growth of organoids from passaged 
hFGOs was dependent on high Wnt and high FGF culture medium, similar to what is used to 
grow primary gastric tissue organoids24,25. Following two rounds of passaging, hFGOs 
maintained expression of lineage markers MUC5AC, MUC6, PGC, and GHRL; however, 
they did not contain PCs and were refractory to PD03/BMP4-mediated induction of the 
parietal lineage (Extended Data Figure 10c–d). This finding was similar to what has been 
observed in adult stem cell-derived gastric organoids, which do not robustly produce PCs 
despite being derived from the bona fide oxyntic mucosa20,26. Thus it will be important to 
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identify conditions that preserve PC competence in long-term cultures of hGOs and adult 
gastric organoids.
In summary, this is one of the first examples in which combined in vivo and in vitro 
discovery-based studies have been directly applied towards the differentiation of hPSCs into 
a new tissue type. We have defined a novel function of Wnt/β-catenin signaling in specifying 
the fundic domain during stomach development in mice, and used Wnt modulation as the 
mechanistic basis to direct differentiation of hPSCs into three-dimensional human fundic 
organoids. In both mouse and human, Wnt-mediated fundus specification was required for 
the subsequent formation of PCs. The fundus-specific manipulations at each stage of this 
directed differentiation protocol were essential to robust PC induction (Extended Data 
Figure 8f), emphasizing the importance of methodically reproducing the embryonic 
signaling environment. Previous reports identified that the mesenchymal factor Barx1 
indirectly acts to repress Wnt signaling and that helps to prevent intestinal gene expression 
in the stomach14,15. Given that the current study identified an epithelial Wnt/β-catenin 
function, and the previous work identified a mesenchymal pathway, it seems likely that Wnt/
β-catenin may have distinct roles in the epithelium versus mesenchyme. For example, the 
mesenchymal role for Wnt/β-catenin could modulate other signaling pathways such as 
BMP27, which our data show synergizes with Wnt to promote intestinal specification from 
early endoderm (7 and Extended Data Figure 4c) The human gastric organoid systems might 
be useful, in combination with animal models, to dissect how these signaling pathways 
interact in the mesenchyme and epithelium to coordinate early embryonic gastrointestinal 
development.
Pathways that control differentiation of gastric progenitor cells into distinct lineages are also 
lacking. We demonstrated the utility of this new hGO platform to identify that MEK/ERK 
signaling potently represses parietal cell specification. Consistent with these findings, 
transgenic activation of MEK/MAPK-dependent pathways led to loss of parietal cells in 
vivo28,29. Therefore, hGOs are a new and tractable human model system to identify and 
study signaling mechanisms involved in normal cellular homeostasis in the fundus and 
antrum. Further, aberrant regulation of developmental programs may also contribute to 
gastric disease, as corpus/fundus pathology is often associated with parietal cell 
atrophy30–32, antral-type histology33, and even misexpression of Pdx134. Thus targeting of 
these pathways could have clinical utility, as Choi et. al. recently demonstrated that 
pharmacologic inhibition of MEK was sufficient to restore normal parietal cell 
differentiation in a mouse model of metaplasia35. Additionally, having now established both 
antral- and fundic-type hGOs, it is possible to study how these human gastric tissues interact 




The following genetic mouse strains were obtained from The Jackson Laboratory, housed at 
Cincinnati Children’s Hospital Research Foundation animal facility, and maintained 
according to IACUC protocol (0B09074): Axin2:LacZ (stock no. 009120), Shh:Cre (stock 
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no. 005622), and β-cateninfloxed (stock no. 004152). Timed matings, with the morning the 
vaginal plug was observed being denoted as E0.5, were used to generate embryos at various 
stages that were harvested for either wholemount staining or tissue dissection. At least two 
litters of embryos were analyzed at each developmental stage examined. Both male and 
female embryos were analyzed.
Pluripotent stem cell culture
Human embryonic stem cell line WA01 (H1; obtained from WiCell) was supplied by the 
Pluripotent Stem Cell Facility at Cincinnati Children’s Hospital Medical Center. Cell 
identity was confirmed by short tandem repeat analysis (Microsatellite STR Analysis; 
Applied Biosystems), and cells were routinely tested for mycoplasma contamination 
(MycoAlert Mycoplasma Detection Kit; Lonza). Pluripotent cells were maintained in feeder-
free conditions on HESC-qualified Matrigel (BD Biosciences) in mTesR1 media (Stem Cell 
Technologies). Colonies were passaged every four days using dispase (Invitrogen).
Differentiation of posterior foregut spheroids
The protocol for directed differentiation of gastric organoids was adapted from our previous 
protocol7, and Supplementary Table 1 contains the complete list of media and growth factors 
for each stage. For differentiation, hPSCs were dissociated into single cells using Accutase 
(Stem Cell Technologies) and plated into 24-well plates at a density of roughly 200,000 cells 
per well in mTesR1 with Y-27632 (10 μM; Stemgent). The following day, cells were 
differentiated into definitive endoderm (DE) by adding Activin A (100 ng/ml; Cell Guidance 
Systems) in RPMI 1640 media (Invitrogen) for three days. Media was also supplemented 
with NEAA (1×; Gibco) and defined FBS (dFBS; Invitrogen) at 0%, 0.2%, and 2.0% on 
days 1, 2, and 3, respectively. Additionally, BMP4 (50 ng/ml; R&D Systems) was added on 
the first day. Subsequently, DE was differentiated to posterior foregut endoderm by exposing 
cells to CHIR99021 (2 μM; Stemgent), FGF4 (500 ng/ml; R&D Systems), and Noggin (200 
ng/ml; R&D systems) for three days in RPMI 1640 supplemented with NEAA and 2.0% 
dFBS. Retinoic acid (2 μM; Sigma Aldrich) was added for the final day. Media was changed 
every day. This process resulted in the spontaneous formation of three-dimensional posterior 
foregut spheroids.
Three-dimensional culture of foregut spheroids-gastric organoids
Posterior foregut spheroids were collected and transferred to a three-dimensional culture 
system as previously described36. Briefly, spheroids were suspended in 50 μl Matrigel (BD 
Biosciences) and plated as a droplet into 24-well plates. The matrigel was allowed to 
solidify for 10 minutes in the tissue culture incubator, then overlayed with basic gut media 
(BGM) containing growth factors and/or small molecule agonsists. BGM consisted of 
Advanced DMEM/F12 media (Gibco) supplemented with N2 (1×; Invitrogen), B27 (1×; 
Invitrogen), HEPES (10 μM; Gibco), L-glutamine, penicillin/streptomycin, and EGF (100 
ng/ml; R&D Systems). During days 6–9, spheroids were cultured with RA and noggin to 
specify the antral lineage. For fundic specification, CHIR was added during this stage. 
Antral hGOs were subsequently cultured in BGM with only EGF. Fundic hGOs were 
continuously exposed to CHIR from day 6–30. In addition, FGF10 (50 ng/ml; R&D 
Systems) was added to fundic hGOs from day 20–30 as it was shown to enhance the 
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glandular morphogenesis driven by CHIR (data not shown). On day 20, organoids were 
collected and re-plated at a dilution of 1:10–1:20.
For screening experiments to identify factors that increase parietal cell differentiation, 
hFGOs were grown to day 30, then exposed for two days to individual signaling pathway 
agonists and antagonists: DAPT (1 μM; Stemgent), SB431542 (10 μM; Stemgent), BMP4 
(50 ng/ml; R&D Systems), PD0325901 (2 μM; Stemgent), Gastrin (10 nM; Sigma Aldrich), 
Dexamethasone (50 nM; Sigma Aldrich), and Wnt5a (50 ng/ml; R&D Systems). Following 
treatment, hFGOs were grown for two more days to day 34, then analyzed by qPCR.
RNA isolation and qPCR
Total RNA was isolated using Nucleospin RNA II kit (Machery Nagel) and converted to 
cDNA as previously described7. qPCR was performed on Quantstudio 6 (Applied 
Biosystems) using Quantitect SYBR-Green master mix (Qiagen), and primer sequences are 
listed below.
Primer Sequences
Primers used for qPCR were the following: hATP4A, forward 5′-
TGGTAGTAGCCAAAGCAGCC-3′, reverse 5′-TGCCATCCAGGCTAGTGAG-3′; 
hATP4B, forward 5′-ACCACGTAGAAGGCCACGTA-3′, reverse 5′-
TGGAGGAGTTCCAGCGTTAC-3′; hAXIN2, forward 5′-
CTGGTGCAAAGACATAGCCA-3′, reverse 5′-AGTGTGAGGTCCACGGAAAC-3′; 
hCCK, forward 5′-CGGTCACTTATCCTGTGGCT-3′, reverse 5′-
CTGCGAAGATCAATCCAGCA-3′; hCDX2, forward 5′-
CTGGAGCTGGAGAAGGAGTTTC-3′, reverse 5′-
ATTTTAACCTGCCTCTCAGAGAGC-3′; hCHGA, forward 5′-
TGACCTCAACGATGCATTTC-3′, reverse 5′-CTGTCCTGGCTCTTCTGCTC-3′; 
hGAPDH, forward 5′-CCCATCACCATCTTCCAGGAG-3′, reverse 5′-
CTTCTCCATGGTGGTGAAGACG-3′; hGAST, forward 5′-
CAGAGCCAGTGCAAAGATCA-3′, reverse 5′-AGAGACCTGAGAGGCACCAG-3′; 
hGATA4, forward 5′-TCCAAACCAGAAAACGGAAGC-3′, reverse 5′-
GCCCGTAGTGAGATGACAGG-3′; hGHRL, forward 5′-
GCTGGTACTGAACCCCTGAC-3′, reverse 5′-GATGGAGGTCAAGCAGAAGG-3′; 
hGIF, forward 5′-CATTTTCCGCGATATTGTTG-3′, reverse 5′-
GCACAGCGCAAAAATCCTAT-3′; hIRX2, forward 5′-GTGGTGTGCGCGTCGTA-3′, 
reverse 5′-GGCGTTCAGCCCCTACC-3′; hIRX3, forward 5′-
GGAGAGAGCCGATAAGACCA-3′, reverse 5′-AGTGCCTTGGAAGTGGAGAA-3′; 
hIRX5, forward 5′-GGTGTGTGGTCGTAGGGAGA-3′, reverse 5′-
GCTACAACTCGCACCTCCA-3′; hMIST1, forward 5′-TGCTGGACATGGTCAGGAT-3′, 
reverse 5′-CGGACAAGAAGCTCTCCAAG-3′; hMUC2, forward 5′-
TGTAGGCATCGCTCTTCTCA-3′, reverse 5′-GACACCATCTACCTCACCCG-3′; 
hMUC5AC, forward 5′-CCAAGGAGAACCTCCCATAT-3′, reverse 5′-
CCAAGCGTCATTCCTGAG-3′; hMUC6, forward 5′-
CAGCAGGAGGAGATCACGTTCAAG-3′, reverse 5′-
GTGGGTGTTTTCCTGTCTGTCATC-3′; hPDX1, forward 5′-
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CGTCCGCTTGTTCTCCTC-3′, reverse 5′-CCTTTCCCATGGATGAAGTC-3′; hSCT, 
forward 5′-GGTTCTGAAACCATAGGCCC-3′, reverse 5′-
GTCAGGGTCCAACATGCC-3′; hSOX2, forward 5′-GCTTAGCCTCGTCGATGAAC-3′, 
reverse 5′-AACCCCAAGATGCACAACTC-3′; mCdx2, forward 5′-
TCTGTGTACACCACCCGGTA-3′, reverse 5′-GAAACCTGTGCGAGTGGATG-3′; 
mGata4, forward 5′-CCATCTCGCCTCCAGAGT-3′, reverse 5′-
CTGGAAGACACCCCAATCTC-3′; mGapdh, forward 5′-
TTGATGGCAACAATCTCCAC-3′, reverse 5′-CGTCCCGTAGACAAAATGGT-3′; mIrx1, 
forward 5′-AATAAGCAGGCGTTGTGTGG-3′, reverse 5′-
CTCAGCCTCTTCTCGCAGAT-3′; mIrx2, forward 5′-AGCTGGTATGGATAGGCCG-3′, 
reverse 5′-GGCTTCCCGTCCTACGTG-3′; mIrx3, forward 5′-
ATAAGACCAGAGCAGCGTCC-3′, reverse 5′-GTGCCTTGGAAGTGGAGAAA-3′; 
mIrx5, forward 5′-GGAGTGTGGTCGTAGGGAGA-3′, reverse 5′-
GCTACAACTCGCACCTCCA-3′; mPdx1, forward 5′-ACGGGTCCTCTTGTTTTCCT-3′, 
reverse 5′-TGGATGAAATCCACCAAAGC-3′; mPitx1, forward 5′-
GTCCATGGAGGTGGGGAC-3′, reverse 5′-GCTTAGGCGCCACTCTCTT-3′; mSox2, 
forward 5′-AAAGCGTTAATTTGGATGGG-3′, reverse 5′-
ACAAGAGAATTGGGAGGGGT-3′; mTrp63, forward 5′- 
AGCTTCTTCAGTTCGGTGGA-3′, reverse 5′- CCTCCAACACAGATTACCCG-3′.
Immunofluorescent staining
Tissues were fixed in 4% paraformaldehyde overnight at 4°C, then washed thoroughly in 
PBS. For wholemount immunofluorescent staining, embryos were processed as previously 
described37. Briefly, they were permeabilized in Dent’s Bleach (4:1:1 EtOH: DMSO: 30% 
H2O2) for two hours at room temperature and rehydrated through series of methanol washes. 
Embryos were then blocked for one hour, incubated in primary antibody overnight at 4°C, 
washed in PBS, incubated in primary antibody overnight at 4°C, and thoroughly washed. For 
paraffin embedding, tissues were dehydrated through series of ethanol washes, washed in 
xylene, then embedded in paraffin. For staining, slides were deparaffinized and rehydrated. 
Antigen retrieval was performed in citrate buffer for 45 minutes in steamer. Primary 
antibodies were incubated overnight at 4°C. Following primary antibody, slides were washed 
in PBS then incubated with secondary antibody (at dilution of 1:500) for one hour at room 
temperature. Secondary antibodies (Jackson ImmunoResearch Laboratories) were made in 
donkey and conjugated to Alexa Fluor 488, 594, or 647.
Primary antibodies
Antibodies used for immunofluorescent staining are listed with antigen, host species, 
manufacturer and catalogue number, and dilution used for staining. Atp4b, rabbit, Santa 
Cruz sc84304, 1:500; Cdh1, goat, R&D Systems AF648, 1:500; Cdh1, mouse, BD 
Biosciences 610182, 1:500; Cdx2, mouse, Biogenex MU392A, 1:500, Cldn18, rabbit, Sigma 
HPA018446, 1:200; Ctnnb1, rabbit, Santa Cruz sc7190, 1:100; FoxF1, goat, R&D Systems 
F4798, 1:500, Gastrin, rabbit, Dako A0568, 1:1,000; Gata4, goat, Santa Cruz sc1237, 1:200; 
Gif, rabbit, Sigma HPA040774, 1:100; Ghrl, goat, Santa Cruz sc10368, 1:200; Histamine, 
rabbit, Immunostar 22939, 1:1,000; Krt8, rat, DSHB troma-1-s; 1:100; Mist1, rabbit, Sigma 
HPA047834, 1:200; Muc5ac, mouse, Abcam ab3649, 1:500; Muc6, mouse, Abcam 
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ab49462, 1:100; Pdx1, goat, Abcam ab47383, 1:5,000; Pgc, sheep, Abcam ab31464, 
1:10,000; Sst, goat, Santa Cruz sc7819, 1:100; Syp, guinea pig, Synaptic Systems 101004, 
1:1,000; Vimentin, goat, Santa Cruz sc7557, 1:200
Imaging
Confocal imaging was performed on Nikon A1Rsi inverted confocal microscope. For 
wholemount imaging, embryos were dehydrated in methanol and cleared in Murray’s clear 
(2:1 benzyl benzoate: benzyl alcohol) just prior to imaging. After staining, slides were 
mounted with Fluoromount G (SouthernBiotech), and air-dried overnight at room 
temperature.
Transmission electron microscopy
For TEM, hGOs were processed as previously described7. Briefly, organoids were fixed in 
3% glutaraldehyde, washed in 0.1 M sodium cacodylate buffer, and incubated for one hour 
4% osmium tetroxide. They were subsequently washed then dehydrated in ethanol series, 
and finally embedded in propylene oxide/LX112. Tissue was then sectioned and stained with 
2% uranyl acetate followed by lead citrate. Images were visualized on Hitachi transmission 
electron microscope.
Pepsinogen ELISA
ELISA was performed using the Human Pepsinogen I (PGI) ELISA Kit (Thermo Scientific, 
EHPGI) according to manufacturer’s instructions. Briefly, day 34 hGOs were collected and 
incubated in Cell Recovery Solution (Corning) for one hour at 4°C then washed in PBS. 
Organoids were lysed with RIPA buffer followed by vigorous vortexing at high velocity for 
30 minutes at room temperature. Lysates were pelleted and supernatant was collected and 
stored at −80°C. For ELISA, the samples and standards were performed in technical 
replicates. The reactions were measured on μQuant microplate plate reader (Bio Tek). 
Absorbance at 450 nm was measured, and the 570 nm absorbance was subtracted.
Acid secretion assays
Acid secretion assays were performed as previously described (Schumacher et al., 2015). 
hGOs were grown in the chambered coverglass (Thermo Scientific) and the chamber was 
placed on an inverted confocal microscope (Zeiss LSM 710), and experiments were 
performed under 5% CO2 and 37°C conditions (incubation chamber, PeCon, Erbach, 
Germany).
Freshly isolated mouse gastric fundic glands or cultured hGO were incubated with acridine 
orange (10 μM), then acridine orange fluorescence was excited at 458 nm or 488 nm and 
images were collected at 600–650 nm (Red) or 500–550 nm (Green), respectively. On the 
other hand, to monitor hGOs luminal pH, the ratiometric pH sensitive dye, 5-(and-6)-
carboxy SNARF-5F (5mM stock: EX 560 nm, EM 565–605 (Green) and 620–680 (Red) nm: 
Invitrogen) was microinjected (46–92 nl) into the lumen and monitored. Fluorescent dye 
also added into medium. Histamine (100 μM; Sigma) was added to media, while famotidine 
(100 μM; Sigma) or omeprazole (100 μM; Sigma) were pre-incubated at least 30 min before 
histamine. Images were analyzed using MetaMorph software (Molecular Devices, 
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Downingtown, PA). Background corrected 620-680/565-605 nm ratio values were converted 
to pH using a standard curve.
Statistical analysis
Statistical significance was determined using unpaired Student’s T-test or one-way ANOVA 
with Dunnett’s multiple comparison post-hoc test. A p value of < 0.05 was considered 
significant.
Statistics and experimental reproducibility
No statistical analysis was used to determine experimental sample size, no specific method 
of randomization was used, and the investigators were not blinded during experiments. 
Statistical methods and measures are described in figure legends. The protocol for 
differentiation of fundic hGOs was successfully completed >20 times by seven independent 
users in the laboratory. In all cases, data shown are derived from a single experiment that is 
representative of multiple experiments.
Data Availability Statement
The source data for the figures 2, 3, 4, 5 and extended data figures 2, 4, 5, 6, 8, 9, and 10 can 
be found in the supplementary information.
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Extended Data Figure 1. Defining molecular domains in the developing stomach in vivo
a, Analysis of Sox2, Pdx1, and Gata4 in the embryonic mouse stomach (E14.5) showed that 
the fundus (f) was Sox2+Gata4+Pdx1−, whereas the antrum (a) was Sox2+Gata4+Pdx1+. The 
forestomach (fs) expressed Sox2 but neither Gata4 nor Pdx1. b, Brightfield 
stereomicrograph showing dissected regions of the E14.5 mouse stomach that were analyzed 
by qPCR. fs, forestomach; f, fundus; a, antrum; d, duodenum. c, Dissected regions in b were 
analyzed by qPCR for known regionally expressed markers (Sox2, P63, Gata4, Pdx1, and 
Cdx2) to validate the accuracy of micro-dissection. qPCR analysis of the dissected E14.5 
stomach regions showed that putative fundus markers Irx1, Irx2, Irx3, Irx5, and Pitx1 were 
enriched in the fundus compared to the antrum. n=4 biological replicates per dissected 
region. Scale bar, 500 μm. Error bars represent s.d.
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Extended Data Figure 2. Analysis of β-catenin cKO embryos
a, By E12.4 and E14.5, ectopic Pdx1 expression was observed throughout the dorsal gastric 
epithelium, as well as the most proximal gastric epithelium of the cKO embryo. b, qPCR 
analysis of dissected regions (as shown in Extended Data Figure 1b) of E14.5 cKO foregut 
showed significant up-regulation of Pdx1 in the fundus and forestomach domains. 
Conversely, Irx2, Irx3, and Irx5 were markedly reduced in these proximal regions. *, 
p<0.05; two tailed Student’s t-test n=3 biological replicates per dissected region for each 
genotype. c, Stereomicrographs of E18.5 dissected viscera demonstrated that cKO embryos 
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exhibited lung agenesis as previously reported. The GI tract, particularly the stomach, was 
dramatically reduced in size. d, Immunofluorescent staining at E18.5 revealed mosaic 
deletion pattern of Ctnnb1. Boxed regions are shown in Figure 1e. e, In the E18.5 cKO 
stomach, recombined glands lacking Ctnnb1 staining did not contain parietal cells whereas 
robust parietal cell differentiation was observed in Ctnnb1-positive glands. Scale bars, 200 
μm (a), 500 μm (d), and 50 μm (e). Error bars represent s.d.
Extended Data Figure 3. Stable induction of fundic fate in hGOs and efficiency of protocol
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a, We investigated how long CHIR treatment was necessary to establish fundus identity. 
Brief CHIR treatment (d6-9) and subsequent growth of organoids in control growth medium 
until day 34 resulted in fundic organoids expressing the antral marker PDX1, suggesting that 
short CHIR treatment did not produce a stable fundic fate. We then tested whether longer 
exposures to CHIR were required to retain fundic fate and found that only continuous 
treatment through at least day 29 could maintain low expression of the antral marker PDX1. 
*, p<0.05 compared to control antral hGOs; two tailed Student’s t-test. n=3 biological 
replicates, data representative of 2 independent experiments. b, c, Over the course of the 
protocol, PDX1 remained low in CHIR-treated organoids, while IRX5 expression was 
persistently elevated. *, p<0.05; two-tailed Student’s t-test; n=3 biological replicates per 
timepoint. d, Conversion of d6 posterior foregut spheroids to early stage gastric organoids 
(d20) is greater than 80% efficient in both the hAGO and hFGO protocols. e, At d20, hFGO 
epithelium is ~90% GATA4+/SOX2+/PDX1- whereas hAGO epithelium is ~90% GATA4+/
SOX2+/PDX1+. **, p<0.001, two-tailed Student’s t-test, n=4 biological replicates per 
experiment, two individual experiments shown. Scale bars, 100 μm (c) and 200 μm (d).
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Extended Data Figure 4. BMP-dependence of Wnt/β-catenin activation to induce intestinal fate 
from foregut progenitors
a, The intestine-specific transcription factor CDX2 was not significantly induced in CHIR-
treated hGOs at either day 9 or day 20. b, Neither fundic nor antral hGOs expressed genes 
associated with intestinal cell types, including MUC2, CCK, and SCT, when compared to 
human intestinal organoids (hIOs). *, p<0.05 compared to hIO; two tailed Student’s t-test. 
n=3 biological replicates. c, Anterior-posterior fate is coordinately controlled by WNT and 
BMP activity. In the presence of the BMP inhibitor Noggin, all organoids maintained foregut 
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(SOX2+) regardless of Wnt/β-catenin pathway activity; however in the presence of BMP4, 
all organoids were posteriorized (CDX2+). Activation of Wnt (CHIR) in a BMP inhibited 
state resulted in fundus pattern (SOX2+, PDX1−, CDX2−) where as activation of WNT 
(CHIR) and addition of BMP4 resulted in an intestinal fate (CDX2+). *, p<0.05 compared to 
analogous Noggin-treated condition; two tailed Student’s t-test. n=3 biological replicates. d, 
Immunofluorescent staining of human tissues revealed that CLDN18 was a gastric-specific 
epithelial marker that is not found in the intestine. Scale bar, 200 μm. Error bars represent 
s.e.m.
Extended Data Figure 5. hFGOs contain organized glands supported by associated mesenchymal 
layer
a, Transmission electron micrographs demonstrated that hFGO glands exhibited organized 
architecture with narrow apical membranes. b, Both hFGOs and hAGOs contained a 
supporting layer FOXF1+/VIM+ undifferentiated fibroblasts. Scale bars, 5 μm (a) and 100 
μm (b).
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Extended Data Figure 6. Region-specific cytodifferentiation in human gastric organoids
a, Antral and fundic hGOs exhibited comparable expression of mucous cell markers 
MUC5AC and MUC6. b, As shown in transmission electron micrograph, hFGOs contained 
abundant cells exhibiting granule pattern consistent with mucous neck cells, the precursors 
to differentiated chief cells. c, Exogenous expression of NEUROG3 in hGOs derived from 
NEUROG3-deficient hESC line induced robust differentiation of SYP-positive endocrine 
cells. While both hAGOs and hFGOs formed GHRL- and SST-expressing endocrine cells, 
specification of GAST+ G-cells was observed only in hAGOs. d, Expression comparison of 
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cell lineage markers in hGOs and human gastric biopsy tissue. qPCR analyses demonstrated 
that hGOs exhibited comparable expression levels of several lineage markers (MUC5AC, 
ATP4B), while other genes were expressed at much lower levels (ATP4A, PGA5, and PGC) 
than found in the fully differentiated, mature human stomach. Scale bars, 5 μm (b) and 100 
μm (c). Error bars represent s.d. (a) and s.e.m. (b).
Extended Data Figure 7. Analysis of murine chief cell development
a, Unlike parietal cells, which expressed functional markers (Atp4b) as early as late 
embryonic stages, chief cell gene products were not detectable until much later stages of 
development. In the embryonic (E18.5) and juvenile (P12) stomach, Gif and Pgc were not 
yet expressed, indicating that chief cells mature much later in development than other 
lineages in the gastric epithelium. b, Despite the absence of Pgc, the P12 mouse stomach did 
contain abundant glandular cells expressing nuclear Mist1, a chief cell-specific marker. 
Thus, chief cells were indeed specified earlier but took several weeks to develop robust 
expression of terminal differentiation markers. Scale bars, 100 μm (a) and 200 μm (b).
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Extended Data Figure 8. Screen for pathways that promote differentiation of parietal cells in 
fundic hGOs
a, To test for growth factors/small molecules capable of inducing parietal cell differentiation, 
hFGOs were exposed for two days (30–32) to the indicated agonist or antagonist and then 
analyzed at day 34. In a screening experiment of different pathways, only MEK inhibition 
with PD03 was found to robustly induce expression of ATP4A/B. b, Reduction or removal 
of EGF from the culture medium was not sufficient to reproduce the effect of MEK 
inhibition. c, The ability of PD03/BMP4 to induce parietal cell development was exclusive 
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to fundic hGOs, as antral hGOs did not express fundic markers in response to PD03/BMP4. 
d, Exposure to PD03/BMP4 rapidly increased expression of ATP4A and ATP4B in fundic 
hGOs. e, Induction of parietal cell generation with PD03/BMP4 did not significantly impact 
the differentiation of chief cells (PGA5 and PGC) and endocrine cells (CHGA). f, The 
manipulations at each stage of the hFGO differentiation protocol was required for robust 
parietal cell differentiation, as removal of any single step led to loss of ATP4A/B expression. 
Error bars represent s.d. (a–c) and s.e.m. (d–f).
Extended Data Figure 9. Live in vitro pH monitoring in gastric organoids
a, The dye SNAFR5F exhibits responsiveness over pH range of 5–8, which makes it well 
suited to detect physiologic changes in response to parietal cell-mediated acid secretion. b, 
Media and luminal pH measurements recorded before (closed circles) and 60 minutes 
following addition of histamine (open circles). Antral hGOs did not respond, while the 
fundic hGO luminal pH decreased in response to histamine. The acidification was inhibited 
by pre-treatment of organoids with either famotidine or omeprazole. Further, omeprazole 
was sufficient to raise the pH in fundic organoids prior to histamine exposure, suggesting a 
baseline acid secretion in the fundic organoids. Media pH did not change in any organoids. 
***, p<0.001 compared to before histamine; $$$, p<0.001 compared to luminal pH without 
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histamine; ###, p<0.001 compared to luminal pH with histamine; two tailed Student’s t-test. 
c, hFGOs contained parietal cell-dense glands in which acridine orange (AO) accumulated in 
nearly all of the cells lining the lumen of the gland. d, AO accumulation was observed in a 
canalicular-type pattern in parietal cells in hFGOs. Scale bars, 10 μm. Error bars represent 
s.d.
Extended Data Figure 10. Serial passaging of human gastric organoids
McCracken et al. Page 23





















a, Schematic representation of experiments to determine the presence of gastric stem cells in 
hGOs. b, When fragments were grown in culture medium containing only EGF, they did not 
grow or expand to form new organoids. However, addition of CHIR and FGF10 to the 
culture medium was sufficient to support the growth of individual fragments into newly 
formed organoids. c, Following two passages, hFGOs still expressed genes consistent with a 
gastric phenotype, including PGC, MUC6, MUC5AC, and GHRL. This ability to undergo 
serial passaging with maintenance of gastric identity supports the conclusion that hFGOs 
contain cells with properties analogous to those of adult gastric stem cells. d, Although 
passaged hFGOs expressed markers associated with several differentiated gastric cell types, 
they did not express genes associated with parietal cells such as ATP4B. Further, 
differentiation of parietal cells could not be induced through MEK inhibition as they could 
prior to passaging. Error bars represent s.d.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
Acknowledgments
We thank J. Whitsett and D. Sinner for providing Axin2-LacZ animals, as well as Y. Zavros, A. Zorn and members 
of the Wells and Zorn laboratories for reagents and feedback. This work was supported by National Institutes of 
Health grants R01DK092456, U19 AI116491, U18EB021780 (J.M.W.), R01DK102551 (M.H.M.), and NIGMS 
Medical Scientist Training Program T32 GM063483. We acknowledge core support from the Cincinnati Digestive 
Disease Center Award (P30 DK0789392), CCHMC Confocal Imaging Core, CCHMC Pluripotent Stem Cell 
Facility, and CCHMC Pathology Core.
References
1. Lancaster MA, Knoblich JA. Organogenesis in a dish: modeling development and disease using 
organoid technologies. Science. 2014; 345:1247125–1247125. [PubMed: 25035496] 
2. Huch M, Koo BK. Modeling mouse and human development using organoid cultures. Development. 
2015; 142:3113–3125. [PubMed: 26395140] 
3. Zhu Z, Huangfu D. Human pluripotent stem cells: an emerging model in developmental biology. 
Development. 2013; 140:705–717. [PubMed: 23362344] 
4. Kim TH, Shivdasani RA. Stomach development, stem cells and disease. Development. 2016; 
143:554–565. [PubMed: 26884394] 
5. Mills JC, Shivdasani RA. Gastric epithelial stem cells. Gastroenterology. 2011; 140:412–424. 
[PubMed: 21144849] 
6. Hoffmann W. Current Status on Stem Cells and Cancers of the Gastric Epithelium. IJMS. 2015; 
16:19153–19169. [PubMed: 26287172] 
7. McCracken KW, et al. Modelling human development and disease in pluripotent stem-cell-derived 
gastric organoids. Nature. 2014; 516:400–404. [PubMed: 25363776] 
8. Noguchi TAK, et al. Generation of stomach tissue from mouse embryonic stem cells. Nature Cell 
Biology. 2015; 17:984–993. [PubMed: 26192439] 
9. Peek RM. Helicobacter pylori infection and disease: from humans to animal models. Disease 
Models & Mechanisms. 2008; 1:50–55. [PubMed: 19048053] 
10. Zorn AM, Wells JM. Vertebrate Endoderm Development and Organ Formation. Annu Rev Cell 
Dev Biol. 2009; 25:221–251. [PubMed: 19575677] 
11. Kraus MRC, Grapin-Botton A. Patterning and shaping the endoderm in vivo and in culture. Curr 
Opin Genet Dev. 2012; 22:347–353. [PubMed: 22742850] 
12. Sherwood RI, Chen TYA, Melton DA. Transcriptional dynamics of endodermal organ formation. 
2009; 238:29–42.
McCracken et al. Page 24





















13. Roth RB, et al. Gene expression analyses reveal molecular relationships among 20 regions of the 
human CNS. Neurogenetics. 2006; 7:67–80. [PubMed: 16572319] 
14. Kim BM, Buchner G, Miletich I, Sharpe PT, Shivdasani RA. The stomach mesenchymal 
transcription factor Barx1 specifies gastric epithelial identity through inhibition of transient Wnt 
signaling. Developmental Cell. 2005; 8:611–622. [PubMed: 15809042] 
15. Kim BM, Woo J, Kanellopoulou C, Shivdasani RA. Regulation of mouse stomach development 
and Barx1 expression by specific microRNAs. Development. 2011; 138:1081–1086. [PubMed: 
21307095] 
16. Rodriguez P, et al. BMP signaling in the development of the mouse esophagus and forestomach. 
Development. 2010; 137:4171–4176. [PubMed: 21068065] 
17. Lameris AL, et al. Expression profiling of claudins in the human gastrointestinal tract in health and 
during inflammatory bowel disease. Scand J Gastroenterol. 2013; 48:58–69. [PubMed: 23205909] 
18. Keeley TM, Samuelson LC. Cytodifferentiation of the postnatal mouse stomach in normal and 
Huntingtin-interacting protein 1-related-deficient mice. Am J Physiol Gastrointest Liver Physiol. 
2010; 299:G1241–51. [PubMed: 20813912] 
19. Choi E, et al. Cell lineage distribution atlas of the human stomach reveals heterogeneous gland 
populations in the gastric antrum. Gut. 2014; 63:1711–1720. [PubMed: 24488499] 
20. Stange DE, et al. Differentiated Troy+ chief cells act as reserve stem cells to generate all lineages 
of the stomach epithelium. Cell. 2013; 155:357–368. [PubMed: 24120136] 
21. Lennerz JKM, et al. The transcription factor MIST1 is a novel human gastric chief cell marker 
whose expression is lost in metaplasia, dysplasia, and carcinoma. Am J Pathol. 2010; 177:1514–
1533. [PubMed: 20709804] 
22. Ramsey VG, et al. The maturation of mucus-secreting gastric epithelial progenitors into digestive-
enzyme secreting zymogenic cells requires Mist1. Development. 2007; 134:211–222. [PubMed: 
17164426] 
23. Lambrecht NWG, Yakubov I, Scott D, Sachs G. Identification of the K efflux channel coupled to 
the gastric H-K-ATPase during acid secretion. Physiological Genomics. 2005; 21:81–91. 
[PubMed: 15613615] 
24. Schumacher MA, et al. The use of murine-derived fundic organoids in studies of gastric 
physiology. J Physiol (Lond). 2015; 593:1809–1827. [PubMed: 25605613] 
25. Barker N, et al. Lgr5(+ve) stem cells drive self-renewal in the stomach and build long-lived gastric 
units in vitro. Cell Stem Cell. 2010; 6:25–36. [PubMed: 20085740] 
26. Bartfeld S, et al. In vitro expansion of human gastric epithelial stem cells and their responses to 
bacterial infection. Gastroenterology. 2015; 148:126–136.e6. [PubMed: 25307862] 
27. Nielsen C, Murtaugh LC, Chyung JC, Lassar A, Roberts DJ. Gizzard Formation and the Role of 
Bapx1. Developmental Biology. 2001; 231:164–174. [PubMed: 11180960] 
28. Goldenring JR, et al. Overexpression of transforming growth factor-alpha alters differentiation of 
gastric cell lineages. Dig Dis Sci. 1996; 41:773–784. [PubMed: 8674399] 
29. Speer AL, et al. Fibroblast growth factor 10-fibroblast growth factor receptor 2b mediated 
signaling is not required for adult glandular stomach homeostasis. PLoS ONE. 2012; 7:e49127. 
[PubMed: 23133671] 
30. Goldenring JR, Nomura S. Differentiation of the gastric mucosa III. Animal models of oxyntic 
atrophy and metaplasia. AJP: Gastrointestinal and Liver Physiology. 2006; 291:G999–1004.
31. Huh WJ, Coffey RJ, Washington MK. Ménétrier’s Disease: Its Mimickers and Pathogenesis. J 
Pathol Transl Med. 2016; 50:10–16. [PubMed: 26689786] 
32. Park YH, Kim N. Review of atrophic gastritis and intestinal metaplasia as a premalignant lesion of 
gastric cancer. J Cancer Prev. 2015; 20:25–40. [PubMed: 25853101] 
33. Weis VG, Goldenring JR. Current understanding of SPEM and its standing in the preneoplastic 
process. Gastric Cancer. 2009; 12:189–197. [PubMed: 20047123] 
34. Nomura S, et al. Evidence for Repatterning of the Gastric Fundic Epithelium Associated With 
Ménétrier’s Disease and TGFα Overexpression. Gastroenterology. 2005; 128:1292–1305. 
[PubMed: 15887112] 
McCracken et al. Page 25





















35. Choi E, Hendley AM, Bailey JM, Leach SD, Goldenring JR. Expression of Activated Ras in 
Gastric Chief Cells of Mice Leads to the Full Spectrum of Metaplastic Lineage Transitions. 
Gastroenterology. 2015; 0
36. McCracken KW, Howell JC, Spence JR, Wells JM. Generating human intestinal tissue from 
pluripotent stem cells in vitro. Nature Protocols. 2011; 6:1920–1928. [PubMed: 22082986] 
37. Ahnfelt-Ronne J, et al. An Improved Method for Three-dimensional Reconstruction of Protein 
Expression Patterns in Intact Mouse and Chicken Embryos and Organs. Journal of Histochemistry 
and Cytochemistry. 2007; 55:925–930. [PubMed: 17478445] 
McCracken et al. Page 26





















Figure 1. Wnt/β-catenin signaling is required for specification of the embryonic fundus in mice
a, Pdx1 and Sox2 were expressed in the antrum (a), whereas Pdx1 was absent in the fundus 
(f), identified by Atp4b-expressing parietal cells at E18.5. b, X-gal staining of an E10.5 
foregut from an Axin2:LacZ reporter embryo showed that Wnt activity was restricted to the 
anterior domain of the stomach but excluded from the posterior stomach. c, Deletion of β-
catenin in the gastric epithelium caused an anterior expansion of Pdx1 into the fundic region 
of the stomach. d, In E18.5 Shh-cre;β-cateninfl/fl (cKO) embryos, Pdx1 was expressed 
throughout the stomach, except in some remaining patches of parietal cell-containing 
epithelium. Insets 1a-c and 2a-c show boxed regions in control and cKO stomach, 
respectively. e, In the cKO stomach, Ctnnb1 exhibited mosaic deletion, and parietal cells 
only differentiated in Ctnnb1-sufficient epithelium. Scale bars, 250 μm (a), 200 μm (c), and 
500 μm (d and e).
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Figure 2. β-catenin activation promotes fundus development from human foregut progenitor 
spheroids
a, Schematized diagram of differentiation protocol for both fundic and antral hGOs. b, c, At 
day 9, CHIR-treated organoids exhibited reduction in PDX1, increase in IRX2, IRX3, and 
IRX5, and no change in gastric markers SOX2 or GATA4. *, p<0.05; two-tailed Student’s t-
test; n=3 biological replicates, data representative of 4 independent experiments. d, hFGOs 
grew comparably to hAGOs, but also exhibited glandular budding morphogenesis (white 
arrowheads). e, Both hGOs contained epithelium that expressed CDH1, KRT8, and 
CTNNB1, as well as gastric markers GATA4 and CLDN18. hAGOs exhibited nearly 
ubiquitous PDX1 expression while hFGOs did not. Scale bars, 50 μm (c), 500 μm (d) and 
100 μm (e). Error bars represent s.e.m.
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Figure 3. Differentiation of mucous and endocrine cell lineages in hGOs
a, Schematic of the shared and distinct lineages found in fundic and antral glands of the 
stomach. b, Both antral and fundic hGOs contained MUC5AC-positive surface mucous cells 
and MUC6-positive mucous neck cells. c, d, hFGOs contained endocrine cells expressing 
the pan-endocrine marker SYP. Diverse hormone cell types were identified in hFGOs, 
including GHRL-, SST-, and histamine-expressing endocrine cells. The antral-specific G-
cell marker GAST was expressed in hAGOs but not hFGOs; conversely, GHRL was 
enriched in hFGOs. **, p<0.01; two-tailed Student’s t-test; n=8 and 24 biological replicates 
in hAGOs and hFGOs respectively, data representative of 6 independent experiments. e, 
hAGOs, but not hFGOs, were competent to give rise to antral-specific GAST-expressing 
endocrine cells in response to expression of the pro-endocrine transcription actor NEUROG3 
(+dox). *, p<0.01; two-tailed Student’s t-test; n=4 biological replicates, data representative 
of 3 independent experiments. Error bars represent s.e.m.
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Figure 4. Formation of chief cells in hFGOs
a, hFGOs had a both MIST1 and Pepsinogen C (PGC) positive cells. b, High magnification 
of boxed region in panel (a) showing a gland with a cluster of cells with apical PGC 
staining. c, hFGOs had significantly increased expression of chief cell markers PGA5 
(1,000-fold), PGC (100-fold), and MIST1 (>10-fold) as compared to hAGOs. **, p<0.05; 
two-tailed Student’s t-test. n=3 biological replicates, data representative of 4 independent 
experiments. d, Transmission electron micrograph of an hFGO cell containing dense 
zymogen granules, indicative of a chief cell. e, Pepsinogen protein content in hFGOs as 
compared to hAGOs in the presence or absence of the MEK inhibitor (PD03). **, p<0.0001 
compared to hAGOs, two-tailed Student’s t-test, n=8, 12, and 11 biological replicates in 
hAGOs, control hFGOs and hFGOs (no PD03), respectively. Scale bars, 200 μm (a), 25 μm 
(b), and 10 μm (d). Error bars represent s.e.m.
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Figure 5. Identification of pathways that drive differentiation of functional parietal cells in 
hFGOs
a, Expression of parietal cell genes ATP4, ATP4B, and GIF exhibited 10–100-fold increase 
in hFGOs compared to antral at baseline, but was dramatically increased by exposing 
hFGOs to a two-day pulse of PD03/BMP4. **, p<0.05 compared to hAGOs; #, p<0.05 
compared to control hFGOs, two-tailed Student’s t-test, n=4 biological replicates, data 
representative of 15 independent experiments. b, Stimulated differentiation of ATP4B-
expressing parietal cells following treatment with PD03/BMP4. c, hFGO-derived parietal 
cells resembled those found in the maturing mouse fundic epithelium in vivo. d, 
Transmission electron micrograph of an hFGO cell with canalicular structure reminiscent of 
parietal cells. e, The epithelium of human fundic glands and hFGO epithelium were 
organized into MUC5AC-expressing cells in the surface epithelium and ATP4B-expressing 
parietal cells in the glandular units. f, Analysis of luminal pH in organoids in response to 
histamine by luminal injection of SNARF-5F. The luminal pH in hFGOs rapidly dropped, 
while hAGOs exhibited no response. The acidification was blocked by pretreating the 
organoids with either famotidine or omeprazole. n=9, 9, 7, and 4 biological replicates in 
hFGOs (histamine), hFGOs (histamine and famotidine), hFGOs (histamine and 
omeprazole), and hAGOs (histamine), respectively; data representative of three independent 
experiments. g, Histamine induced acridine orange (AO) dye accumulation in a canalicular-
type pattern in isolated mouse gastric glands and in hFGOs after 60 minutes. Scale bars, 100 
μm (b), 10 μm (c), 10 μm (d), 100 μm (e; human fundus), 20 μm (e; hFGO), and 10 μm (g). 
Error bars represent s.e.m.
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